Jane Street’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137M Buy
2,265,508
+2,102,131
+1,287% +$123M 0.02% 518
2025
Q4
$8.81M Sell
163,377
-3,808,661
-96% -$183M ﹤0.01% 2477
2025
Q3
$179M Buy
3,972,038
+3,458,290
+673% +$162M 0.03% 381
2025
Q2
$23.8M Buy
513,748
+62,881
+14% +$3.09M ﹤0.01% 1290
2025
Q1
$27.5M Sell
450,867
-2,243,506
-83% -$131M 0.01% 1052
2024
Q4
$152M Buy
2,694,373
+374,509
+16% +$20.9M 0.03% 313
2024
Q3
$120M Sell
2,319,864
-1,793,970
-44% -$84.2M 0.03% 345
2024
Q2
$171M Buy
4,113,834
+2,706,696
+192% +$121M 0.04% 244
2024
Q1
$76.3M Sell
1,407,138
-3,147,431
-69% -$160M 0.02% 455
2023
Q4
$234M Buy
4,554,569
+962,744
+27% +$50.5M 0.06% 189
2023
Q3
$208M Buy
3,591,825
+3,144,431
+703% +$193M 0.07% 154
2023
Q2
$28.6M Buy
447,394
+305,108
+214% +$20.5M 0.01% 913
2023
Q1
$9.86M Sell
142,286
-408,463
-74% -$28.8M ﹤0.01% 1650
2022
Q4
$39.6M Buy
550,749
+357,427
+185% +$27M 0.02% 632
2022
Q3
$13.7M Sell
193,322
-934,622
-83% -$67.8M 0.01% 1397
2022
Q2
$86.9M Sell
1,127,944
-366,786
-25% -$27.9M 0.04% 348
2022
Q1
$109M Buy
1,494,730
+977,710
+189% +$65.6M 0.04% 350
2021
Q4
$32.2M Buy
517,020
+422,631
+448% +$24.8M 0.01% 865
2021
Q3
$5.58M Sell
94,389
-707,080
-88% -$46.6M ﹤0.01% 2567
2021
Q2
$53.6M Buy
801,469
+225,592
+39% +$14.7M 0.02% 523
2021
Q1
$36.4M Buy
575,877
+354,101
+160% +$22M 0.02% 610
2020
Q4
$13.8M Sell
221,776
-317,159
-59% -$19.5M 0.01% 1150
2020
Q3
$32.5M Sell
538,935
-367,816
-41% -$22.1M 0.02% 548
2020
Q2
$53.3M Buy
906,751
+551,879
+156% +$33M 0.04% 339
2020
Q1
$19.8M Sell
354,872
-395,434
-53% -$24.2M 0.02% 466
2019
Q4
$48.2M Buy
750,306
+617,646
+466% +$35.4M 0.07% 189
2019
Q3
$6.73M Buy
132,660
+29,623
+29% +$1.39M 0.01% 798
2019
Q2
$4.67M Sell
103,037
-514,034
-83% -$23.9M 0.01% 1095
2019
Q1
$29.4M Buy
617,071
+579,045
+1,523% +$28.8M 0.05% 294
2018
Q4
$1.98M Sell
38,026
-84,875
-69% -$4.56M ﹤0.01% 1745
2018
Q3
$7.63M Buy
122,901
+8,154
+7% +$484K 0.02% 769
2018
Q2
$6.35M Buy
114,747
+23,560
+26% +$1.27M 0.01% 865
2018
Q1
$5.77M Buy
91,187
+48,458
+113% +$3.12M 0.01% 870
2017
Q4
$2.62M Sell
42,729
-121,055
-74% -$7.57M 0.01% 1339
2017
Q3
$10.4M Buy
163,784
+133,418
+439% +$7.79M 0.03% 500
2017
Q2
$1.69M Sell
30,366
-9,968
-25% -$542K 0.01% 1648
2017
Q1
$2.19M Sell
40,334
-121,908
-75% -$6.69M 0.01% 1302
2016
Q4
$9.48M Buy
162,242
+56,599
+54% +$3.09M 0.04% 377
2016
Q3
$5.7M Buy
105,643
+78,501
+289% +$5.04M 0.03% 538
2016
Q2
$2M Buy
27,142
+2,610
+11% +$184K 0.01% 1277
2016
Q1
$1.57M Sell
24,532
-21,610
-47% -$1.36M 0.01% 1408
2015
Q4
$3.17M Buy
46,142
+40,278
+687% +$2.66M 0.02% 735
2015
Q3
$347K Sell
5,864
-15,315
-72% -$972K ﹤0.01% 2640
2015
Q2
$1.41M Sell
21,179
-31,518
-60% -$2.08M 0.01% 1258
2015
Q1
$3.4M Buy
52,697
+44,653
+555% +$2.8M 0.03% 570
2014
Q4
$475K Buy
+8,044
New +$454K ﹤0.01% 1516
2014
Q2
Sell
-27,770
Closed -$1.44M 2561
2014
Q1
$1.44M Buy
27,770
+10,326
+59% +$549K 0.02% 726
2013
Q4
$927K Buy
17,444
+7,311
+72% +$372K 0.01% 828
2013
Q3
$469K Sell
10,133
-41,868
-81% -$1.84M 0.01% 1757
2013
Q2
$2.32M Buy
+52,001
New +$2.26M 0.04% 392

Other funds holding BMY

Jane Street's BMY Position: Q1 2026 in Review

Jane Street increased its Bristol-Myers Squibb (BMY) stake by 1,287% in Q1 2026, buying an estimated $123M and bringing the position to 2,265,508 shares worth $137M. The position accounts for 0.02% of the portfolio, ranked #518.

Jane Street first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $234M in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Jane Street held 2,265,508 shares of Bristol-Myers Squibb worth $137M as of Q1 2026.
  • Jane Street bought 2,102,131 Bristol-Myers Squibb shares in Q1 2026, an estimated $123M.
  • Bristol-Myers Squibb made up 0.02% of Jane Street's portfolio in Q1 2026, its #518 holding.
  • Jane Street first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
  • Jane Street's Bristol-Myers Squibb position peaked at $234M in Q4 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.